Rhumatologie

Achievement of a patient acceptable symptom state (PASS) and of a minimum clinically important improvement (MCII) with etanercept in refractory heel enthesitis related to spondyloarthritis: Results of a double blind placebo controlled study (HEEL)

Arthritis&Rheum.2009;60(10 suppl):S669(P1786)

M Dougados, B Combe, J Braun, R Landewé, J Sibilia, A Cantagrel, V Leblanc, I Logeart

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France
Rhumatologie

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France

Cost utility modeling of early vs late total knee replacement in osteoarthritis patients.
Rhumatologie

Cost utility modeling of early vs late total knee replacement in osteoarthritis patients.

Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis
Rhumatologie

Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis